- Home
- SCNI vs NDRA Comparison
SCNI vs NDRA Comparison
Compare SCNI & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- NDRA
- Stock Information
- Founded
- SCNI 2003
- NDRA 2007
- Country
- SCNI Israel
- NDRA United States
- Employees
- SCNI N/A
- NDRA N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SCNI Health Care
- NDRA Health Care
- Exchange
- SCNI Nasdaq
- NDRA Nasdaq
- Market Cap
- SCNI 1.9M
- NDRA 2.1M
- IPO Year
- SCNI N/A
- NDRA 2017
- Fundamental
- Price
- SCNI $2.55
- NDRA $3.98
- Analyst Decision
- SCNI
- NDRA Strong Buy
- Analyst Count
- SCNI 0
- NDRA 1
- Target Price
- SCNI N/A
- NDRA $50.00
- AVG Volume (30 Days)
- SCNI 18.0K
- NDRA 355.0K
- Earning Date
- SCNI 05-14-2025
- NDRA 05-13-2025
- Dividend Yield
- SCNI N/A
- NDRA N/A
- EPS Growth
- SCNI N/A
- NDRA N/A
- EPS
- SCNI 8.20
- NDRA N/A
- Revenue
- SCNI $452,000.00
- NDRA N/A
- Revenue This Year
- SCNI N/A
- NDRA N/A
- Revenue Next Year
- SCNI N/A
- NDRA N/A
- P/E Ratio
- SCNI $0.30
- NDRA N/A
- Revenue Growth
- SCNI N/A
- NDRA N/A
- 52 Week Low
- SCNI $1.90
- NDRA $2.97
- 52 Week High
- SCNI $8.92
- NDRA $665.00
- Technical
- Relative Strength Index (RSI)
- SCNI 45.49
- NDRA 51.65
- Support Level
- SCNI $1.90
- NDRA $3.28
- Resistance Level
- SCNI $2.54
- NDRA $3.98
- Average True Range (ATR)
- SCNI 0.29
- NDRA 0.92
- MACD
- SCNI 0.04
- NDRA 0.02
- Stochastic Oscillator
- SCNI 47.71
- NDRA 31.76
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.